Exelixis (NASDAQ: EXEL) is without question one of the hottest biotech stocks on the market. We're talking about a stock that has more than tripled in value in just the last 12 months and has soared over 70% so far this year. Exelixis is, …
NWI6mon
The top stocks to watch today (Thursday) are Incyte Corp. (Nasdaq ... Lastly, don't forget that the markets will be closed tomorrow in observance of Good Friday. Incyte stock is up 1.2% in early morning trading after analysts upgraded their …
Unfortunately, Incyte posted a loss on the year despite making an incredibly recovery from its February lows. Looking ahead, one analyst sees solid upside for this stock. Credit Suisse has an Outperform rating with a $137 price target, …
Incyte, a $25 billion biotech company, revealed some new data about its cancer drugs on Wednesday, and the stock popped. The drugmaker, which has one approved product to treat bone-marrow disorders, is developing a cancer …
Shares of Incyte Corporation closed the previous trading session at 132.00 up +3.30 2.56% with 1,038,399 shares …
Incyte Corp. has joined the prestigious Standard & Poor's 500, an index of the 500 most widely held stocks on the New York Stock Exchange and Nasdaq. Incyte's addition to the S&P 500 is significant both as a status symbol and as an …
Incyte Corporation INCY reported third-quarter earnings of 11 cents (including the impact of a change in fair value of acquisition-related contingent consideration and unrealized gain on long term investment). The Zacks Consensus …